The independent source for health policy research, polling, and news.
201 - 220 of 1,684 Results
Paxlovid has eclipsed other available therapies for preventing life-threatening covid symptoms in high-risk patients. But even as doctors praise its effectiveness, many say they have unanswered questions about prescribing the drug and want more and better data about it.
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven't received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others arent sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.
KHN gives readers a chance to comment on a recent batch of stories.
This episode is an interview with Dr. Thomas Fisher, author of "The Emergency: A Year of Healing and Heartbreak in a Chicago ER."
The pandemic disrupted all sense of normalcy for U.S. hospitals, so federal officials are proposing to pause financial penalties against the facilities and to block public access to key hospital safety data such as the frequency of falls and sepsis because of concerns that the data isnt accurate enough. But consumer advocates are furious about the proposal.
Anti-vaccine advocates discovered a catchy, succinct, and potent slogan. Its unlikely source: the abortion rights movement.
The drugmaker has the best-selling vaccine to prevent covid and the most effective drug to treat it. Its success has overshadowed the governments covid-fighting strategy.
The Supreme Courts decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Angela Hart, who reported and wrote the latest KHN-NPR Bill of the Month episode about two identical eye surgeries with very different price tags.
KHN gives readers a chance to comment on a recent batch of stories.
The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHNs Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
In carrying out the federal covid-19 test-to-treat initiative, California is targeting the uninsured by outfitting 138 testing sites with screenings for free antiviral drugs. But as of mid-June, fewer than 800 people had been prescribed the medicines. And two-thirds of those undergoing screenings are insured.
One million Americans have died from covid-19 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nations pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.
Researchers say the billions in pandemic funding available for ventilation upgrades in U.S. schools provides a once-in-a-generation opportunity to combat covid-19, as well as making air more breathable for students living with allergies, asthma, and chronic wildfire smoke.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Heres a collection of their appearances.
The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicares trustees board.
Stemming gun violence is back on the legislative agenda following three mass shootings in less than a month, but its hard to predict success when so many previous efforts have failed. Meanwhile, lawmakers must soon decide if they will extend current premium subsidies for those buying health insurance under the Affordable Care Act, and the Biden administration acts, belatedly, on Medicare premiums. Margot Sanger-Katz of the New York Times, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat News join KHNs Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHNs Michelle Andrews, who reported and wrote the latest KHN-NPR Bill of the Month episode about a too-common problem: denial of no-cost preventive care for a colonoscopy under the Affordable Care Act.
KHN gives readers a chance to comment on a recent batch of stories.
Some foster children with complex mental, behavioral, and physical health needs without a foster placement are having to stay in hotel rooms and even office buildings, a practice called hoteling.
Although identifying long covid in older adults can be tricky, experts say there are good strategies for getting medical advice and fighting the impact of the virus.
穢 2026 KFF